Skip to main content

Table 1 Summary of reported cases of Brevundimonas vesicularis infection in humans

From: Case report: Infective endocarditis caused by Brevundimonas vesicularis

Reference Age (y)/sex Underlying disease Clinical presentation Treatment/duration Outcome
(8)/NI 54/F SLE, autoimmune hepatitis, steroid therapy Necrotizing cellulitis Tobramycin + ceftazidime/30d Survival
(9)/NI 42/F Mitral valve stenosis s/p mitral valve replacement Septicaemia Piperacillin - tazobactam/14d Survival
(10)/CA 5/M Sickle cell anemia Pneumonia Ceftriaxone + gentamicin/10d Survival
(11)/NI 59–67/both Hemodialysis Septicaemia Cefotaxime + tobramycin/unknown Survival
(12)/CA 60/M Trauma Botryomycosis Cefuroxime- axetil/4 months Survival
(13)/CA 38/M No Acute tonsillitis amoxicillin- clavulanate/3d Survival
(14)/CA 1.25/F No Septic arthritis cefuroxime/12d + oral cephalexin/14d Survival
(15)/CA 55/M Continuous ambulatory peritoneal dialysis peritonitis ceftazidime/3d, ceftazidime + vancomycin/4d, ciprofloxacin + aztreonam/14d Survival
current case/CA 40/M No Subacute endocarditis cefazolin + gentamicin/3 d, Ampicillin/sulbactam + gentamicin/5 d, Ceftriaxone + gentamicin/7 d, ciprofloxacin/30 d Survival
  1. Abbreviations:
  2. CA = community-acquired infection;
  3. NI: nosocomial infection. Nosocomial infections are those that originate or occur in a hospital if they first appear 48 hours or more after admission or hospital-like settings.